CONVERTING-ENZYME INHIBITOR ENALAPRIL (MK 421) IN TREATMENT OF HYPERTENSION WITH RENAL ARTERY STENOSISHODSMAN GP; BROWN JJ; DAVIES DL et al.1982; BRITISH MEDICAL JOURNAL; ISSN 0007-1447; GBR; DA. 1982; VOL. 285; NO 6356; PP. 1697-1699; BIBL. 17 REF.Article

"SCALDED MOUTH" CAUSED BY ANGIOTENSIN-CONVERTING-ENZYME INHIBITORSVLASSES PH; ROTMENSCH HH; FERGUSON RK et al.1982; BR. MED. J.; ISSN 0007-1447; GBR; DA. 1982; VOL. 284; NO 63300; PP. 1672-1673; BIBL. 5 REF.Article

Low-affinity state betal-adrenoceptor-induced vasodilation in SHRMOHAMED YASSINE MALLEM; RECULEAU, Olivier; LE COZ, Olivier et al.Peptides (New York, NY. 1980). 2005, Vol 26, Num 8, pp 1463-1467, issn 0196-9781, 5 p.Conference Paper

Preference of Patient Information Leaflets over Standard Drug Monographs by Patients Prescribed Hydrochlorothiazide, Nifedipine and EnalaprilGOSSELL-WILLIAMS, M; BENNETT, O; DIAS, Y et al.West indian medical journal. 2012, Vol 61, Num 3, pp 271-279, issn 0043-3144, 9 p.Article

Omapatrilat and enalapril in patients with hypertension: The Omapatrilat Cardiovascular Treatment vs. Enalapril (OCTAVE) trialKOSTIS, John B; PACKER, Milton; BLACK, Henry R et al.American journal of hypertension. 2004, Vol 17, Num 2, pp 103-111, issn 0895-7061, 9 p.Article

Converting-enzyme inhibitor administration lowers urinary free 19-nor-deoxycorticosterone levelsGRIFFING, G. T; WILSON, T. E; MELBY, J. C et al.Hypertension (Dallas, Tex. 1979). 1985, Vol 7, Num 2, pp 178-181, issn 0194-911XArticle

ENALAPRL MALEATE AND A LYSINE ANALOGUE (MK-521): DISPOSITION IN MANULM EH; HICHENS M; GOMEZ HJ et al.1982; BR. J. CLIN. PHARMACOL.; ISSN 0306-5251; GBR; DA. 1982; VOL. 14; NO 3; PP. 357-362; BIBL. 15 REF.Article

TOTAL SERUM ANGIOTENSIN CONVERTING ENZYME ACTIVITY IN RATS AND DOGS AFTER ENALAPRIL MALEATE (MK-421)ULM EH; VASSIL TC.1982; LIFE SCI. (1973); ISSN 0024-3205; GBR; DA. 1982; VOL. 30; NO 14; PP. 1225-1230; BIBL. 15 REF.Article

Management of posttransplant erythrocytosis with enalaprilJAVID, R; GHAHRAMANI, N; MALEK-HOSSEINI, S. A et al.Transplantation proceedings. 1999, Vol 31, Num 8, issn 0041-1345, p. 3226Conference Paper

Comparison of effects of quinapril versus enalapril on vasoactive substances following acute myocardial infarctionTSIKOURIS, James P; SIMONI, Jan; SUAREZ, Jose A et al.The American journal of cardiology. 2004, Vol 94, Num 5, pp 641-643, issn 0002-9149, 3 p.Article

The Effect of Enalapril on Skin Flap Viability is Independent of Angiotensin II AT1 ReceptorsPAZOKI-TOROUDI, Hamidreza; AJAMI, Marjan; HABIBEY, Rouhollah et al.Annals of plastic surgery. 2009, Vol 62, Num 6, pp 699-702, issn 0148-7043, 4 p.Article

Enalapril treatment and hospitalization with atrial tachyarrhythmias in patients with left ventricular dysfunctionALSHEIKH-ALI, Alawi A; WANG, Paul J; RAND, William et al.The American heart journal. 2004, Vol 147, Num 6, pp 1061-1065, issn 0002-8703, 5 p.Article

In vivo enalapril-induced acantholysisSCHIAVO, A. L; GUERRERA, V; COZZANI, E et al.Dermatology (Basel). 1999, Vol 198, Num 4, pp 391-393, issn 1018-8665Conference Paper

Quantitative analysis of enalapril by ¹H NMR spectroscopy in tabletsZOPPI, Ariana; LINARES, Marcela; LONGHI, Marcela et al.Journal of pharmaceutical and biomedical analysis. 2005, Vol 37, Num 3, pp 627-630, issn 0731-7085, 4 p.Article

Effects of the angiotensin-converting enzyme inhibitor enalapril on blood haematopoietic progenitors and Acetyl-N-Ser-Asp-Lys-Pro concentrationsCOMTE, L; LORGEOT, V; VOLKOV, L et al.European journal of clinical investigation. 1997, Vol 27, Num 9, pp 788-790, issn 0014-2972Article

Angio-oedème et inhibiteurs d'enzyme de conversion (IEC) = Angio-oedema and ACE inhibitorsREVERTE, M; ROGER, H; FERRIER-LEBOUEDEC, M. C et al.Les Nouvelles dermatologiques. 1994, Vol 13, Num 9, issn 0752-5370, p. 701Conference Paper

Blood pressure response to conventional and low-dose enalapril in chronic renal failureELUNG-JENSEN, Thomas; HEISTERBERG, Jens; KAMPER, Anne-Lise et al.British journal of clinical pharmacology. 2003, Vol 55, Num 2, pp 139-146, issn 0306-5251, 8 p.Article

Protective effects of enalapril, an angiotensin-converting enzyme inhibitor, on multiple organ damage following scald injury in ratsZHANG, Bing-Qian; GUANG WANG; HUANG, Yue-Sheng et al.Biotechnology and applied biochemistry. 2012, Vol 59, Num 4, pp 307-313, issn 0885-4513, 7 p.Article

Enalapril-induced cough is associated with non-severe heart failureSADANAGA, Tsuneaki; YOSHIMURA, Michihiro; SAKAMOTO, Tomohiro et al.International journal of cardiology. 2009, Vol 135, Num 2, pp 275-276, issn 0167-5273, 2 p.Article

Bioequivalence study of enalapril tablets in healthy Thai male volunteersLOHITNAVY, Ornrat; TAYTIWAT, Prawit; LOHITNAVY, Manupat et al.Chot Mai Het Thang Phaet. 2002, Vol 85, Num 6, pp 716-721, issn 0125-2208, 6 p.Article

THE PHYSIOLOGICAL DISPOSITION AND METABOLISM OF ENALAPRIL MALEATE IN LABORATORY ANIMALSTOCCO DJ; DE LUNA FA; DUNCAN AEW et al.1982; DRUG METAB. DISPOS.; ISSN 0090-9556; USA; DA. 1982; VOL. 10; NO 1; PP. 15-19; BIBL. 10 REF.Article

Intracellular and not intraluminal esterolysis of enalapril in kidney: Studies with the single pass perfused nonfiltering rat kidneySIRIANNI, G. L; SANDY PANG, K.Drug metabolism and disposition. 1998, Vol 26, Num 4, pp 324-331, issn 0090-9556Article

Enalapril (MK-421), a new angiotensin-converting enzyme inhibitor: acute and chronic effects in heart failureDUNKMAN, W. B; WILEN, M; FRANCIOSA, J. A et al.Chest. 1983, Vol 84, Num 5, pp 539-545, issn 0012-3692Article

Bioequivalence study of two brands of enalapril tablets after single oral administration to healthy volunteersNIOPAS, I; DAFTSIOS, A. C; NIKOLAIDIS, N et al.International journal of clinical pharmacology and therapeutics. 2003, Vol 41, Num 5, pp 226-230, issn 0946-1965, 5 p.Article

THE RENIN-ANGIOTENSIN SYSTEM IN REFRACTORY HEART FAILURE: CLINICAL, HEMODYNAMIC AND HORMONAL EFFECTS OF CAPTOPRIL AND ENALAPRILTURINI GA; WAEBER B; BRUNNER HR et al.1983; EUR. HEART J.; ISSN 0195-668X; GBR; DA. 1983; VOL. 4; SUPPL. A; PP. 189-197; BIBL. 47 REF.Article